| Date Filed | Type | Description |
| 10/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
4
| Cole Douglas G. (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Disposed/sold 683 options to buy
@ $6.6439, valued at
$4.5k
Disposed/sold 683 options to buy
@ $4.9984, valued at
$3.4k
|
|
| 06/09/2023 |
4
| Cole Douglas G. (Director) has filed a Form 4 on Sana Biotechnology, Inc.|
Txns:
| Granted 65,000 options to buy
@ $6.7, valued at
$435.5k
|
|
| 06/05/2023 |
4
| Cole Douglas G. (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 4,216 shares
@ $0
Granted 12,649 options to buy
@ $30.92, valued at
$391.1k
|
|
| 06/22/2022 |
4
| Cole Douglas G. (Director) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 16,000 options to buy
@ $13.81, valued at
$221k
|
|
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Cole Douglas G. (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Granted 8,888 options to buy
@ $0.7632, valued at
$6.8k
|
|
| 07/14/2021 |
4
| Cole Douglas G. (Director) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 12,530 options to buy
@ $9.4, valued at
$117.8k
|
|
| 06/28/2021 |
4
| Cole Douglas G. (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Granted 8,888 options to buy
@ $9.97, valued at
$88.6k
|
|
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Cole Douglas G. (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Exercised 3,253 restricted stock units
@ $0 |
|
| 02/18/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/03/2020 |
3
| Cole Douglas G. (Director) has filed a Form 3 on Sigilon Therapeutics, Inc. |
| 10/22/2020 |
3
| Cole Douglas G. (Director) has filed a Form 3 on Foghorn Therapeutics Inc. |
| 06/05/2020 |
4
| Cole Douglas G. (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 15,183 options to buy
@ $28.82, valued at
$437.6k
Granted 3,253 restricted stock units
@ $0 |
|
| 05/31/2019 |
4
| Cole Douglas G. (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 27,245 options to buy
@ $19.5, valued at
$531.3k
|
|
| 01/04/2019 |
4
| Cole Douglas G. (Director) has filed a Form 4 on Quanterix Corp|
Txns:
| Granted 2,270 shares
@ $0
Granted 7,900 options to buy
@ $18.24, valued at
$144.1k
|
|
| 08/09/2018 |
4
| Cole Douglas G. (Director) has filed a Form 4 on Quanterix Corp|
Txns:
| Granted 2,270 shares
@ $0
Granted 7,900 options to buy
@ $14.8, valued at
$116.9k
|
|
| 06/15/2018 |
4
| Cole Douglas G. (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 27,830 options to buy
@ $18.92, valued at
$526.5k
|
|
| 12/08/2017 |
4
| Cole Douglas G. (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 47,165 options to buy
@ $18, valued at
$849k
|
|
| 12/07/2017 |
3
| Cole Douglas G. (Director) has filed a Form 3 on Denali Therapeutics Inc. |
| 12/06/2017 |
3
| Cole Douglas G. (Director) has filed a Form 3 on Quanterix Corp |
| 08/21/2017 |
4
| Cole Douglas G. (Director) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Acquired 1,686 shares
@ $0 |
|
| 06/19/2017 |
4
| Cole Douglas G. (Director) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 11,538 options to buy
@ $15.63, valued at
$180.3k
|
|
| 08/11/2016 |
4
| Cole Douglas G. (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Acquired 917 shares
@ $0 |
|
| 06/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/25/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/25/2014 |
4
| Cole Douglas G. (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Acquired 1,861 shares
@ $0 |
|
| 06/05/2014 |
4
| Cole Douglas G. (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Granted 12,500 options to buy
@ $35.16, valued at
$439.5k
|
|
| 07/19/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|